Abstract
The curved, gram-negative bacterium Vibrio cholerae is the cause of cholera, a severe and potentially lethal diarrheal disease. The disease has been recognized since ancient times and descriptions of cholera can be found in Sanskrit texts dating back to 500 B.C. (1) Besides its often dramatic clinical presentation, two epidemiologic features distinguish cholera from other diarrheal diseases. These are the tendency of cholera to appear in explosive outbreaks and its predilection for pandemic spread. The explosiveness of a cholera outbreak was sadly witnessed in 1994 with the massive death counts in the refugee camps of Goma, Zaire.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Barua, D., 1992, History of cholera, in: Cholera (D. Barua and W. B. Greenough III, eds.), Plenum Press, New York, pp. 1–36.
Shimada, T., Nair, G. B., Deb, B. C., Albert, M.J., Sack, R. B., and Takeda, Y, 1993, Outbreak of Vibrio cholerae non-Ol in India and Bangladesh, Lancet 341:1347.
Wachsmuth, I. K., Blake, P. A., and Olsvik, Ø. (eds.), 1994, Vibrio cholerae and Cholera: Molecular to Global Perspectives, ASM Press, Washington, D.C.
Barua, D., and Greenough, W. B., 1992, Cholera, Plenum Medical, New York.
Kaper, J. B., Morris, J. G., and Levine, M. M., 1995, Cholera, Clin. Microbiol. Rev. 8:48–86.
Shimada, T., Arakawa, E., Itoh, K., Okitsu, T., Matsushima, A., Asai, Y., Yamai, S., Nakazato, T., Nair, G. B., Albert, M. J., and Takeda, Y, 1994, Extended serotyping scheme for Vibrio cholerae, Curr. Microbiol. 28:175–178.
Morris, J. G., 1990, Non-O group 1 Vibrio cholerae. A look at the epidemiology of an occasional pathogen, Epidemiol. Rev. 12:179–191.
Wachsmuth, I. K., Evins, G. M., Fields, P. I., Olsvik, O., Popovic, T., Bopp, C. A., Wells, J. G., Carrillo, C., and Blake, P. A., 1993, The molecular epidemiology of cholera in Latin America, J. Infect. Dis. 167:621–626.
Manning, P. A., Stroeher, U. H., and Morona, R., 1994, Molecular basis for O-antigen biosynthesis in Vibrio cholerae O1: Ogawa-Inaba switching, in: Vibrio cholerae and Cholera: Molecular to Global Perspectives (I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik, eds.), ASM Press, Washington, D.C., pp. 77–94.
Siddique, A. K., Baqui, A., Eusof, A., Haider, K., Hossain, M., Bashir, I., and Zaman, K., 1991, Survival of classic cholera in Bangladesh, Lancet 337:1125–1127.
Popovic, T., Bopp, C., Olsvik, Ø., and Wachsmuth, I. K., 1993, Epidemiologic application of a standardized ribotype scheme for Vibrio cholerae Ol, J. Clin. Microbiol. 31:2474–2482.
Taylor, R., Shaw, C., Peterson, K., Spears, P., and Mekalanos, J., 1988, Safe, live Vibrio cholerae vaccines? Vaccine 6:151–154.
Waldor, M. K., and Mekalanos, J. J., 1994, ToxR regulates virulence gene expression in non-Ol strains of Vibrio cholerae that cause epidemic cholera, Infect. Immun. 62:72–78.
Calia, K. E., Murtagh, M., Ferraro, M. J., and Calderwood, S. B., 1994, Comparison of Vibrio cholerae O139 with V. cholerae Ol classical and El Tor biotypes, Infect. Immun. 62:1504–1506.
Cholera Working Group, 1993, Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal, Lancet 342:387–390.
Hall, R. H., Khambaty, F. M., Kothary, M., and Keasler, S. D., 1993, Non-Ol Vibrio cholerae, Lancet 342:430.
Waldor, M. K., and Mekalanos, J.J., 1994, Vibrio choleraeO139 specific gene sequences, Lancet 343:1366.
Waldor, M. K., Colwell, R., and Mekalanos, J. J., 1994, The Vibrio cholerae O139 serogroup antigen includes O-antigen capsule and lipopolysaccharide virulence determinants, Proc. Natl. Acad. Sci. USA 91:11388–11392.
Bik, E. M., Bunschoten, A. E., Gouw, R. D., and Mooi, E, 1995, Genesis of the novel epidemic Vibrio cholerae O139 strain: Evidence for horizontal transfer of genes involved in polysac-charide synthesis, EMBO J. 14:209–216.
Mintz, E. D., Popovic, T., and Blake, P. A., 1994, Transmission of Vibrio choleraeOl, in: Vibrio cholerae and Cholera: Molecular to Global Perspectives (I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik, eds.), ASM Press, Washington, D. C., pp. 345–356.
Levine, M. M., Kaper, J. B., Black, R. E., and Clements, M. L., 1983, New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development, Microbiol. Rev. 47:510–550.
Finkelstein, R. A., 1992, Cholera enterotoxin (choleragen): A historical perspective, in: Cholera (D. Barua and W. B. Greenough III, eds.), Plenum Press, New York, pp. 155–187.
Gabriel, S. E., Brigman, K. N., Koller, B. H., Boucher, R. C., and Stutts, M. J., 1994, Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model, Science 266:107–109.
Peterson, J. W., and Ochoa, G. L., 1989, Role of prostaglandins and cAMP in the secretory effects of cholera toxin, Science 245:857–859.
Cassuto, J., Jodal, M., Tuttle, R., and Lundgren, O., 1981, On the role of intramural nerves in cholera toxin induced intestinal secretion, Scand. J. Gastroenterol. 16:377–384.
Pearson, G. D., and Mekalanos, J. J., 1982, Molecular cloning of Vibrio cholerae enterotoxin genes in Escherichia coli K-12, Proc. Natl. Acad. Sci. USA 79:2976–2980.
Mekalanos, J. J., Swartz, D. J., Pearson, G. D., Harford, N., Groyne, E, and deWilde, M., 1983, Cholera toxin genes: Nucleotide sequence, deletion analysis and vaccine development, Nature 306:551–557.
Kaper, J. B., Lockman, H., Balini, M., and Levine, M. M., 1984, Recombinant nontox-inogenic Vibrio cholerae strains as attenuated cholera vaccine candidates, Nature 308: 655–658.
Pearson, G. D. N., Woods, A., Chiang, S. L., and Mekalanos, J.J., 1993, CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor, Proc. Natl. Acad. Sci. USA 90:3750–3754.
Fasano, A., Baudry, B., Pumplin, D. W., Wasserman, S. S., Tall, B. D., Ketley, J. N., and Kaper, J. B., 1991, Vibrio cholerae produces a second enterotoxin which affects intestinal tight junctions, Proc. Natl. Acad. Sci. USA 88:5242–5246.
Trucksis, M., Galen, J., Michalski, J., Fasano, A., and Kaper, J. B., 1993, Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette, Proc. Natl. Acad. Sci. USA 90:5267–5271.
Levine, M. M., Kaper, J. B., Herrington, D., Losonsky, G., Morris J. G., Clements, M., Black, R. E., Tall, B., and Hall, R., 1988, Volunteer studies of deletion mutants of Vibrio cholerae Ol prepared by recombinant techniques, Infect. Immun. 56:161–167.
Mekalanos, J. J., and Sadoff, J. C., 1994, Cholera vaccines: Fighting an ancient scourge, Science 265:1387–1389.
Koonin, E. V., 1992, The second cholera toxin, Zot, and its plasmid-encoded and phage-encoded homologues constitute a group of putative ATP-ases with an altered purine NTP-binding motif, FEBS Lett. 312:3–6.
Taylor, D. N., Killeen, K. P., Hack, D. C., Kenner, J. R., Coster, T. S., Beattie, D. T., Ezzell, J., Hyman, T., Troga, A., Sjogren, M. H., Friedlander, A., Mekalanos, J. J., and Sadoff, J. C., 1994, Development of a live, oral, attenuated vaccine against El Tor cholera, J. Infect. Dis. 170:1518–1523.
Tacket, C. O., Losonsky, G., Nataro, J. P., Cryz, S. J., Edelman, R., Fasano, A., Michalski, J., Kaper, J. B., and Levine, M. M., 1993, Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a ΔctxA Δzot Δ ace derivative of El Tor Ogawa Vibrio cholerae, J. Infect. Dis. 168:1536–1540.
Honda, T., and Finkelstein, R. A., 1979, Purification and characterization of a hemolysin produced by Vibrio cholerae biotype El Tor: Another toxic substance produced by cholera vibrios, Infect. Immun. 26:1020–1027.
Ichinose, Y., Yamamoto, K., Nakasone, N., Tanabe, M. J., Takeda, T., Miwatani, T., and Iwanaga, M., 1987, Enterotoxicity of El Tor-like hemolysin of non-Ol Vibrio cholerae, Infect. Immun. 55:1090–1093.
O’Brien, A. D., Chen, M. E., Holmes, R. K., Kaper, J., and Levine, M. M., 1984, Environmental and human isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin, Lancet 1:77–78.
Saha, S., and Sanyal, S. C., 1988, Cholera toxin gene-positive Vibrio cholerae Ol Ogawa and Inaba strains produce the new cholera toxin, FEMS Microbiol. Lett. 50:113–116.
Pierce, N. F., Kaper, J. B., Mekalanos, J. J., and Cray, W. J., 1985, Role of cholera toxin in enteric colonization by Vibrio cholerae Ol in rabbits, Infect. Immun. 50:813–816.
Freter, R., O’Brien, P. C. M., and Macsai, M. M. S., 1981, Role of chemotaxis in the association of motile bacteria with intestinal mucosa in vivo studies, Infect. Immun. 34: 234–240.
Taylor, R. K., Miller, V. L., Furlong, D. B., and Mekalanos, J. J., 1987, Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin, Proc. Natl. Acad. Sci. USA 84:2833–2837.
Kaufman, M. R., and Taylor, R. K., 1994, The toxin-coregulated pilus: Biogenesis and function, in: Vibrio cholerae and Cholera: Molecular to Global Perspectives (I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik, eds.), ASM Press, Washington, D.C., pp. 187–202.
Ogierman, M. A., Zabihi, S., Mourtzios, L., and Manning, P. A., 1993, Genetic organization and sequence of the promoter-distal region of the tcp gene cluster of Vibrio cholerae, Gene 126: 51–60.
Kaufman, M. R., Shaw, C. E., Jones, I. D., and Taylor, R. K., 1993, Biogenesis and regulation of the Vibrio cholerae toxin-coregulated pilus: Analogies to other virulence factor secretory systems, Gene 126:43–49.
Peek, J. A., and Taylor, R. K., 1992, Characterization of a periplasmic thiol:disulfide interchange protein required for the functional maturation of secreted virulence factors of Vibrio cholerae, Proc. Natl. Acad. Sci. USA 89:6210–6214.
Herrington, D. A., Hall, R. H., Losonsky, G., Mekalanos, J. J., Taylor, R. K., and Levine, M. M., 1988, Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans, J. Exp. Med. 168:1487–1492.
Rhine, J. A., and Taylor, R. K., 1994, TcpA pilin sequences and colonization requirements for Ol and O139 Vibrio cholerae, Mol. Microbiol. 13:1013–1020.
Attridge, S. R., Voss, E., and Manning, P. A., 1993, The role of toxin-coregulated pili in the pathogenesis of Vibrio cholerae Ol El Tor, Microb. Pathog. 15:421–431.
Parsot, C., Taxman, E., and Mekalanos, J. J., 1991, ToxR regulates the production of lipoproteins and the expression of serum resistance in Vibrio cholerae, Proc. Natl. Acad. Sci. USA 88:1641–1645.
Everiss, K. D., Hughes, K.J., Kovach, M. E., and Peterson, K. M., 1994, The Vibrio cholerae acfB colonization determinant encodes an inner membrane protein that is related to a family of signal-transducing proteins, Infect. Immun. 62:3289–3298.
Peterson, K. M., and Mekalanos, J. J., 1988, Characterization of the Vibrio cholerae ToxR regulon: Identification of novel genes involved in intestinal colonization, Infect. Immun. 56:2822–2829.
Gardel, C. L., and Mekalanos, J. J., 1994, Modus operandi of Vibrio cholerae. Swim to arrive, stop to kill. The relationship among chemotaxis, motility and virulence, J. Cell Biochem. 18A:65.
Franzon, V. L., Barker, A., and Manning, P. A., 1993, Nucleotide sequence encoding the mannose-fucose resistant hemagglutinin of Vibrio cholerae Ol and construction of a mutant, Infect. Immun. 61:3032–3037.
Jonson, G., Lebens, M., and Holmgren, J., 1994, Cloning and sequencing of Vibrio cholerae mannose-sensitive haemagglutinin pilin gene: Localization of mshA within a cluster of type 4 pilin genes, Mol. Microbiol. 13:109–118.
Finkelstein, R. A., Boesman-Finkelstein, M., Chang, Y, and Hase, C. C., 1992, Vibrio cholerae hemagglutinin/protease, colonial variation, virulence, and detachment, Infect. Immun. 60: 472–478.
Henderson, D. P., and Payne, S. M., 1994, Vibrio cholerae iron transport systems: Roles of heme and siderophore iron transport in virulence and identification of a gene associated with multiple iron transport systems, Infect. Immun. 62:5120–5125.
Goldberg, M. B., DiRita, V. J., and Calderwood, S. B., 1990, Identification of an iron-regulated virulence determinant in Vibrio cholerae, using TnphoA mutagenesis, Infect. Immun. 58:55–60.
Camilli, A., Beattie, D., and Mekalanos, J., 1994, Use of genetic recombination as a reporter of gene expression, Proc. Natl. Acad. Sci. USA 91:2634–2638.
Overbye, L. J., Sandkvist, M., and Bagdasarian, M., 1993, Genes required for extracellular secretion of enterotoxin are clustered in Vibrio cholerae, Gene 132:101–106.
Hall, R. H., Vial, P. A., Kaper, J. B., Mekalanos, J. J., and Levine, M. M., 1988, Morphological studies on fimbriae expressed by Vibrio cholerae Ol, Microb. Pathog. 4:257–65.
Baselski, V. S., Medina, R. A., and Parker, C. D., 1979, In vivo and in vitro characterization of virulence deficient mutants of Vibrio cholerae, Infect. Immun. 24:111–116.
Ottemann, K. M., and Mekalanos, J. J., 1994, Regulation of cholera toxin expression, in: Vibrio cholerae and Cholera: Molecular to Global Perspectives (I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik, eds.), ASM Press, Washington, D.C., pp. 177–185.
DiRita, V.J., 1992, Co-ordinate expression of virulence genes by ToxR in Vibrio cholerae, Mol. Microbiol. 6:451–458.
Lang, H., Jonson, G., Holmgren, J., and Palva, E. T., 1994, The maltose regulon of Vibrio cholerae affects production and secretion of virulence factors, Infect. Immun. 62:4781–4788.
Litwin, C. M., and Calderwood, S. B., 1994, Analysis of the complexity of gene regulation by Fur in Vibrio cholerae, J. Bacteriol. 176:240–248.
Williams, S. G., Attridge, S. R., and Manning, P. A., 1993, The transcriptional activator HlyU of Vibrio cholerae. Nucleotide sequence and role in virulence gene expression, Mol. Microbiol. 9:751–760.
Richardson, S. H., 1994, Host susceptibility, in: Vibrio cholerae and Cholera: Molecular to Global Perspectives (I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik, eds.), ASM Press, Washington, D.C., pp. 273–292.
Levine, M. M., and Pierce, N. F., 1992, Immunity and vaccine development, in: Cholera (D. Barua and W. B. Greenough III, eds.), Plenum Press, New York, pp. 285–328.
Clemens, J. D., Sack, D. A., Harris, J. R., Chakraborty, J., Khan, M., Huda, S., Ahmed, F., Goes, J., Rao, M., Svennerholm, A., and Holmgren, J., 1989, ABO blood groups and cholera: New observations on specificity of risk and modification of vaccine efficacy, J. Infect. Dis. 159:770–773.
Glass, R. I., Svennerholm, A. M., Khan, M. R., Huda, S., Huq, M. I., and Holmgren, J., 1985, Seroepidemiological studies of El Tor cholera in Bangladesh: Association of serum antibody levels with protection, J. Infect. Dis. 151:236–242.
Clemens, J. D., Van Loon, R., Sack, D., Rao, M., Ahmed, F., Chakraborty J., Kay, B., Khan, M., Yunus, M., Harris, J., Svennerholm, A., and Holmgren, J., 1991, Biotype as determinant of natural immunising effect of cholera, Lancet 337:883–884.
Svennerholm, A.-M., Jonson, G., and Holmgren, J., 1994, Immunity to Vibrio cholerae infection, in: Vibrio cholerae and Cholera: Molecular to Global Perspectives (I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik, eds.), ASM Press, Washington, D.C., pp. 257–272.
Hall, R. H., Losonsky, G., Silveira, A. P., Taylor, R. K., Mekalanos, J. J., Witham, N. D., and Levine, M. M., 1991, Immunogenicity of Vibrio cholerae Ol toxin-coregulated pili in experimental and clinical cholera, Infect. Immun. 59:2508–2512.
Sun, D. X., Mekalanos, J. J., and Taylor, R. K., 1990, Antibodies directed against the toxin-coregulated pilus isolated from Vibrio cholerae provide protection in the infant mouse experimental cholera model, J. Infect. Dis. 161:1231–1236.
Cash, R. A., Music, S. I., Libonati, J. P., Criag, J. P., Pierce, N. F., and Hornick, R. B., 1974, Reponse of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine, J. Infect. Dis. 130:325–333.
Winner, L. D., Mack, J., Weltzin, R., Mekalanos, J. J., Kraehenbuhl, J. P., and Neutra, M. R., 1991, New model for analysis of mucosal immunity: Intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection, Infect. Immun. 59:977–982.
Holmgren, J., Lycke, N., and Czerkinsky, C., 1993, Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems, Vaccine 11:1179–1184.
Lycke, N., Tsuji, T., and Holmgren, J., 1992, The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity, Eur. J. Immunol. 22:2277–2281.
McKenzie, S., and Halsey, J., 1984, Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response, J. Immunol. 133:1818–1822.
Kraehenbuhl, J. P., and Neutra, M. R., 1992, Molecular and cellular basis of immune protection of mucosal surfaces, Physiol. Rev. 72:853–879.
Sun, J.-B., Holmgren, J., and Czerkinsky, C., 1994, Cholera toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance, Proc. Natl. Acad. Sci. USA 91:10795–10799.
Xu-Amano, J., Kiyono, H., Jackson, R., Staats, H., Fujihashi, K., Burrows, P., Elson, C. O., Pillai, S. and McGhee, J. R., 1993, Helper T cell subsets for immunoglobulin A responses: Oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues, J. Exp. Med. 178:1309–1320.
Clemens, J. D., Harris, J. R., Sack, D. A., Chakraborty J., Ahmed, F., Stanton, B. F., Khan, M. U., Kay, B. A., Huda, N., and Khan, M. R., 1988, Field trial of oral cholera vaccines in Bangladesh: Results of one year of follow-up, J. Infect. Dis. 158:60–69.
Clemens, J. D., Sack, D. A., Harris, J. R., Loon, F. V., Chakraborty J., Ahmed, F., Rao, M. R., Khan, M. R., Yunus, M. and Huda, N., 1990, Field trial of oral cholera vaccines in Bangladesh: Results from three-year follow-up, Lancet 335:270–273.
Owen, R. L., Pierce, M. R., Apple, R. T., and Cray, W. C., 1986, M cell transport of Vibrio cholerae from the intestinal lumen into Peyer’s patches: A mechanism for antigen sampling and for microbial transepithelial migration, J. Infect. Dis. 153:1108–1118.
Waldor, M. K., and Mekalanos, J. J., 1994, Emergence of a new cholera pandemic: Molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype, J. Infect. Dis. 170:278–283.
Clemens, J. D., Sack, D. A., Harris, J. R., Chakraborty, J., Neogy, P. K., Stanton, B., Huda, N., Khan, M. U., Kay, B. A., and Khan, M. R., 1988, Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxi-genic Escherichia coli. Results of a large-scale field trial, J. Infect. Dis. 158:372–377.
Coster, T. S., Killeen, K. P., Waldor, M. K., Beattie, D., Spriggs, D., Kenner, J. R., Trofa, A., Sadoff, J., Mekalanos, J. J., and Taylor, D. N., 1995, Safety, immunogenicity and efficacy of a live attenuated Vibrio cholerae O139 vaccine protype, Bengal-15, Lancet 345:949–952.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Waldor, M.K., Mekalanos, J.J. (1996). Vibrio cholerae. In: Paradise, L.J., Bendinelli, M., Friedman, H. (eds) Enteric Infections and Immunity. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0313-6_3
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0313-6_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0315-0
Online ISBN: 978-1-4899-0313-6
eBook Packages: Springer Book Archive